|
Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer Clinical Trials Facts presented on Clinical Trials Search isn't designed to be a substitute for proven healthcare advice, calls or treatment using a real mD. We aren't mDs. Always confer with your physician on Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer conditions. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer Clinical research trials and Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer healthcare trials happen in a lot of of localities across the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally measure the potency of new drugs. The aim of the studies / undertakings is to answer particular human medical questions. Clinical trials are a popular manner for doctors, government agencies, and private sector corporations to discover remedies for all kinds of circumstances, such as Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer. Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer Clinical Trials and other clinical trials allow volunteers to get healthcare treatment alternatives before they are available to the general public. Most times the participants receive treatment for without cost, and occasionally they are paid for their time. Sometimes there is a cost for a Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer clinical trial. Human subjects often receive the most effective healthcare possible for their Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer condition. Risks are a reality, nonetheless, and may include more or frequent dr. calls, healthcare hazards (perhaps life-threatening), and/or the treatment being ineffective. Trials are federally governed with rigorous guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "C" Clinical Trials Conditions > Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer  Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer
Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer
For Condition: stage 3A breast cancer,stage 3B breast cancer,stage 2 breast cancer,stage 1 breast cancer
Status: Recruiting
Sponsor(s): National Cancer Institute of Canada , North Central Cancer Treatment Group
Synopsis: RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Colony-stimulating factors such as epoetin alfa and filgrastim may decrease the side effects of chemotherapy. It is not yet known which treatment regimen is most effective for breast cancer. PURPOSE: Randomizedphase III trial to compare the effectiveness of combination chemotherapy given with or without epoetin alfa in treating women who have undergone surgery for stage I, stage II, or stage III breast cancer.
Details: OBJECTIVES: - Compare the disease-free survival and overall survival of premenopausal or early postmenopausal women with previously resected node positive or high-risk node negative stage I-IIIB breast cancer treated with cyclophosphamide, epirubicin, and fluorouracil vs cyclophosphamide, epirubicin, filgrastim (G-CSF), and epoetin alfa followed by paclitaxel vs cyclophosphamide and doxorubicin followed by paclitaxel. - Compare the rate of toxic effects of these regimens in this patient population. - Compare the quality of life of patients treated with these regimens. OUTLINE: This is a randomized, multicenter study. Patients are stratified according to number of positive nodes (0 vs 1-3 vs 4-10 vs more than 10), type of prior surgery (total vs partial mastectomy), and estrogen receptor status (positive vs negative). Patients are randomized to one of three treatment arms. - Arm I: Patients receive epirubicin IV and fluorouracil IV on days 1-8 and oral cyclophosphamide on days 1-14. Treatment repeats every 28 days for 6 courses. - Patients receive epirubicin IV and cyclophosphamide IV on day 1 and filgrastim (G-CSF) subcutaneously (SC) on days 2-13. Patients also receive epoetin alfa SC once weekly beginning within 1 week after start of therapy and continuing (as needed) until completion of therapy. Treatment repeats every 14 days for 6 courses. Beginning 21 days after completion of epirubicin and cyclophosphamide, patients receive paclitaxel IV over 3 hours on day 1 and G-CSF and epoetin alfa as above. Treatment repeats every 21 days for 4 courses. - Patients receive doxorubicin IV over 15 minutes and cyclophosphamide IV over 15 minutes on day 1. Treatment repeats every 21 days for 4 courses. Beginning 21 days after completion of doxorubicin and cyclophosphamide, patients receive paclitaxel as in arm II. Treatment in all arms continues in the absence of disease progression or unacceptable toxicity. All receptor positive patients receive oral tamoxifen or anastrozole (if tamoxifen is contraindicated) for 5 years after completion of chemotherapy. Quality of life is assessed at baseline, weeks 4, 8, 12, and 20 (arm I), weeks 4, 8, 13, and 22 (arm II), weeks 3, 9, 12, and 21 (arm III), 9 months, 12 months, and then annually thereafter. Patients are followed at 9 months, 12 months, every 4 months for 1 year, every 6 months for 3 years, and then annually thereafter. PROJECTED ACCRUAL: A total of 1,500 patients (500 per treatment arm) will be accrued for this study within 3 years.
Eligibility:
Study Type: Interventional, Treatment
Minimum Age/Maximum Age: /60 Years
Genders: Both
Protocol Entry Criteria: DISEASE CHARACTERISTICS: - Histologically confirmed adenocarcinoma of the breast that is potentially curable - T0-4 (dermal involvement on pathology assessment only), N0-2, M0 - No clinical T4 disease - Previously treated with one of the following: - Total mastectomy and level II axillary node dissection - Partial mastectomy and axillary node dissection with planned breast radiotherapy after completion of study (if microscopic residual in situ or invasive disease is present at partial mastectomy margins, planned radiotherapy must also include a boost to the tumor bed) - Sentinel node biopsy (if node positive, must undergo level II axillary node dissection) - No residual tumor in the axilla after dissection - Axillary node positive or high-risk node negative after level II axillary node dissection - Negative nodes allowed if tumor at least 1 cm and one or more of the following is present: - Histological grade III - Estrogen receptor negative - Lymphatic/vascular invasion - Hormone receptor status: - Estrogen receptor status known PATIENT CHARACTERISTICS: Age: - 60 and under Sex: - Female Menopausal status: - Pre- or postmenopausal Performance status: - ECOG 0-2 Life expectancy: - At least 5 years Hematopoietic: - WBC at least 3,000/mm^3 - Platelet count at least 100,000/mm^3 Hepatic: - Bilirubin no greater than 1.5 times upper limit of normal (ULN) Renal: - Creatinine no greater than 1.5 times ULN Cardiovascular: - LVEF at least lower limit of normal by MUGA or echocardiogram - No arrhythmia requiring ongoing treatment - No congestive heart failure - No documented coronary artery disease Other: - No other malignancy except: - Adequately treated basal cell or squamous cell skin cancer or carcinoma in situ of the cervix - Ductal or lobular carcinoma in situ that has been curatively treated by surgery alone - Other prior malignancies (except breast cancer) curatively treated more than 5 years prior to study - No serious underlying medical illness or psychiatric or addictive disorder that would preclude study - No known hypersensitivity to E. coli-derived products, mammalian-cell derived products, or any study agents - Not pregnant or nursing - Negative pregnancy test - Fertile patients must use effective non-hormonal contraception PRIOR CONCURRENT THERAPY: Biologic therapy: - No prior immunotherapy for breast cancer Chemotherapy: - No prior chemotherapy for breast cancer Endocrine therapy: - No prior hormonal therapy for breast cancer - No concurrent hormone replacement therapy - No concurrent selective estrogen-receptor modulators (e.g., raloxifene for the treatment or prevention of osteoporosis) - No concurrent oral contraceptives (i.e., birth control pills) - No other concurrent aromatase inhibitors Radiotherapy: - See Disease Characteristics - No prior radiotherapy for breast cancer Surgery: - See Disease Characteristics - No more than 12 weeks since prior total or partial mastectomy (including re-excision of margins) Other: - At least 30 days since prior investigational drugs - No other concurrent investigational drugs - Concurrent bisphosphonates for the treatment or prevention of osteoporosis allowed
Total Enrollment:
Location and Contact Information:
Overall Study Official:
EdithPerez, Study Chair, Mayo Clinic
Graves-Gilbert Clinic *Recruiting*
Bowling Green, Kentucky, 42102-9007
United States
Recruiting Thomas Young 270-783-3369
Margaret and Charles Juravinski Cancer Centre *Recruiting*
Hamilton, Ontario, L8V 5C2
Canada
Recruiting Mark Levine 905-527-4322, ext. 42176
Green Cancer Center at Scripps Clinic *Recruiting*
La Jolla, California, 92037
United States
Recruiting Richard Just 858-882-8301
St. Luke's Hospital *Recruiting*
Duluth, Minnesota, 55805
United States
Recruiting Tanya Repka 218-726-3081
Creighton University Medical Center *Recruiting*
Omaha, Nebraska, 68131-2197
United States
Recruiting Peter Silberstein 402-280-3432
Saskatoon Cancer Centre *Recruiting*
Saskatoon, Saskatchewan, S7N 4H4
Canada
Recruiting Deepu Mirchandani 306-655-2690
Lawrence M. Stallings Medical Practice *Recruiting*
Wooster, Ohio, 44691
United States
Recruiting Lawrence Stallings 330-262-2800
St. Joseph's Health Centre - Toronto *Recruiting*
Toronto, Ontario, M6R 1B5
Canada
Recruiting John Blondal 416-530-6586
University of Minnesota Cancer Center *Recruiting*
Minneapolis, Minnesota, 55455
United States
Recruiting Douglas Yee 612-625-3636
CCOP - Toledo Community Hospital *Recruiting*
Toledo, Ohio, 43623-3456
United States
Recruiting Paul Schaefer 419-843-6147
Kingston Regional Cancer Centre *Recruiting*
Kingston, Ontario, K7L 5P9
Canada
Recruiting Yolanda Madarnas 613-544-2631
Willis - Knighton South Center for Women's Health *Recruiting*
Shreveport, Louisiana, 71118
United States
Recruiting Robert Nickelson 318-632-5165
Central Baptist Hospital *Recruiting*
Lexington, Kentucky, 40503
United States
Recruiting Lee Hicks 859-260-6065
Cancer Care Ontario-London Regional Cancer Centre *Recruiting*
London, Ontario, N6A 4L6
Canada
Recruiting Theodore Vandenberg 519-685-8640
CCOP - Mayo Clinic Scottsdale Oncology Program *Recruiting*
Scottsdale, Arizona, 85259-5404
United States
Recruiting Tom Fitch 480-301-9875
Lynn Regional Cancer Center West *Recruiting*
Boca Raton, Florida, 33466
United States
Recruiting Peter Radice 561-883-7600
Evansville Cancer Center *Recruiting*
Evansville, Indiana, 47715
United States
Recruiting Rick Ballou 812-474-1110
Peterborough Oncology Clinic *Recruiting*
Peterborough, Ontario, K9H 7B6
Canada
Recruiting Rafal Wierzbicki 905-576-8711 ext. 4044
Ivinson Memorial Hospital *Recruiting*
Laramie, Wyoming, 82070
United States
Recruiting Charles Tweedy 307-742-2141
Toronto General Hospital *Recruiting*
Toronto, Ontario, M5G 2C4
Canada
Recruiting John Gapski 905-848-7160
Allan Blair Cancer Centre *Recruiting*
Regina, Saskatchewan, S4T 7T1
Canada
Recruiting Haji Chalchal 306-766-2691
Ottawa Regional Cancer Centre *Recruiting*
Ottawa, Ontario, K1H 1C4
Canada
Recruiting Susan Dent 613-737-770 ext. 56760
Suburban Hospital Cancer Program *Recruiting*
Bethesda, Maryland, 20817
United States
Recruiting Cheryl Aylesworth 301-897-1503
Toronto Sunnybrook Regional Cancer Centre *Recruiting*
Toronto, Ontario, M4N 3M5
Canada
Recruiting Kathleen Pritchard 416-480-4616
Arlington-Fairfax Hematology/Oncology, PC *Recruiting*
Arlington, Virginia, 22205
United States
Recruiting John Feigert 703-528-7303
Cancer Treatment Center *Recruiting*
Shreveport, Louisiana, 71101-0000
United States
Recruiting Laura Campbell 318-681-4121
Mount Sinai Hospital - Toronto *Recruiting*
Toronto, Ontario, M5G 1X5
Canada
Recruiting Martin Blackstein 416-586-5371
Sparks Regional Medical Center *Recruiting*
Fort Smith, Arkansas, 72901-2418
United States
Recruiting Lester Barnes 479-709-7435
Shands Cancer Center at the University of Florida Health Science Center *Recruiting*
Gainesville, Florida, 32610-0277
United States
Recruiting Barbara Shea 352-392-2995
Sibley Memorial Hospital *Recruiting*
Washington D.C., District of Columbia, 20016
United States
Recruiting Frederick Smith 202-537-4923
Maine Center for Cancer Medicine and Blood Disorders - Scarborough *Recruiting*
Scarborough, Maine, 04074
United States
Recruiting Tracey Weisberg 207-885-7600
St. Louis University Hospital Cancer Center *Recruiting*
St. Louis, Missouri, 63110
United States
Recruiting Paul Petruska 314-577-8854
Nanaimo Cancer Clinic at Nanaimo Regional General Hospital *Recruiting*
Nanaimo, British Columbia, V9S 2B7
Canada
Recruiting Christopher Williams 250-755-7691 ext. 2784
CCOP - Missouri Valley Cancer Consortium *Recruiting*
Omaha, Nebraska, 68106
United States
Recruiting James Mailliard 402-280-4364
St. Michael's Hospital - Toronto *Recruiting*
Toronto, Ontario, M5B 1W8
Canada
Recruiting Rashida Haq 416-864-5912
Consultants in Blood Disorders and Cancer *Recruiting*
Louisville, Kentucky, 40207
United States
Recruiting Daniel Scullin 502-897-1166
James P. Wilmot Cancer Center at University of Rochester Medical Center *Recruiting*
Rochester, New York, 14642
United States
Recruiting Jennifer Griggs 585-275-5863
Genesis Cancer Center *Recruiting*
Hot Springs, Arkansas, 71913
United States
Recruiting R. Webb 501-624-7700
Siouxland Hematology-Oncology *Recruiting*
Sioux City, Iowa, 51101-1733
United States
Recruiting Donald Wender 712-252-0088
Gabrail Cancer Center - Canton Office *Recruiting*
Canton, Ohio, 44718
United States
Recruiting Nashat Gabrail 330-492-33345
Baystate Medical Center *Recruiting*
Springfield, Massachusetts, 01199
United States
Recruiting Grace Makari-Judson 413-794-5433
Orange Park Cancer Center *Recruiting*
Orange Park, Florida, 32073
United States
Recruiting Linda Sylvester 904-272-3139
Drexel University College of Medicine *Recruiting*
Philadelphia, Pennsylvania, 19129
United States
Recruiting Pauline Lerma 215-842-6980
Winthrop University Hospital *Recruiting*
Mineola, New York, 11501
United States
Recruiting Harry Staszewski 516-663-9500
Medical City Dallas Hospital *Recruiting*
Dallas, Texas, 75230
United States
Recruiting Barry Mirtsching 972-566-5588
Hotel Dieu de Montreal *Recruiting*
Montreal, Quebec, H2W 1T8
Canada
Recruiting Claude Potvin 514-890-8000 ext. 25848
Santee Hematology Oncology *Recruiting*
Sumter, South Carolina, 29150
United States
Recruiting Billy Clowney 803-934-8833
Prince Edward Island Cancer Center at Queen Elizabeth Hospital *Recruiting*
Charlottetown, Prince Edward Island, C1A 8T5
Canada
Recruiting Dagny Dryer 902-894-2027
Methodist Hospital Cancer Center at Nebraska Methodist Hospital - Omaha *Recruiting*
Omaha, Nebraska, 68114-4199
United States
Recruiting Robert Langdon 402-354-8124
British Columbia Cancer Agency - Centre for the Southern Interior *Recruiting*
Kelowna, British Columbia, V1Y 5L3
Canada
Recruiting Marianne Taylor 250-712-3996
Greenwich Hospital Association *Recruiting*
Greenwich, Connecticut, 06830
United States
Recruiting Arthur Rosenberg 203-863-3000
St. Joseph Medical Center *Recruiting*
Towson, Maryland, 21204
United States
Recruiting Paul Chang 410-337-4521
CCOP - Cedar Rapids Oncology Project *Recruiting*
Cedar Rapids, Iowa, 52403-1206
United States
Recruiting Martin Wiesenfeld 319-363-8303
Central Montgomery Medical Center *Recruiting*
Lansdale, Pennsylvania, 19446-1200
United States
Recruiting Richard Kosierowski 215-361-4747
University of Chicago Cancer Research Center *Recruiting*
Chicago, Illinois, 60637-1470
United States
Recruiting Ann Mauer 773-702-4138
Newfoundland Cancer Treatment and Research Foundation *Recruiting*
St. Johns, Newfoundland and Labrador, A1B 3V6
Canada
Recruiting Joy McCarthy 709-777-7802
Cancer Associates of Northern Utah *Recruiting*
Ogden, Utah, 84403
United States
Recruiting Vincent Hansen 801-525-8837
Scarborough Hospital - General Site *Recruiting*
Scarborough, Ontario, M1P 2V5
Canada
Recruiting Henry Krieger 416-438-2911
Algoma Reginal Cancer Program at Sault Area Hospital *Recruiting*
Sault Sainte Marie, Ontario, P6B 1Y5
Canada
Recruiting Paul D. Walde 705-759-3434 ext. 4450
CCOP - Wichita *Recruiting*
Wichita, Kansas, 67214-3882
United States
Recruiting Shaker Dakhil 316-268-5784
Hopital Charles Lemoyne *Recruiting*
Greenfield Park, Quebec, J4V 2H1
Canada
Recruiting Pierre Desjardins 450-466-5065
MBCCOP - Hawaii *Recruiting*
Honolulu, Hawaii, 96813
United States
Recruiting Brian Issell 808-586-3013
Pottstown Memorial Regional Cancer Center *Recruiting*
Pottstown, Pennsylvania, 19464
United States
Recruiting Wei Song 610-327-7544
CancerCare Manitoba *Recruiting*
Winnipeg, Manitoba, R3E 0V9
Canada
Recruiting Debjani Grenier 204-787-2127
Mayo Clinic *Recruiting*
Jacksonville, Florida, 32224
United States
Recruiting Edith Perez 904-953-0118
Columbia Comprehensive Cancer Care Clinic *Recruiting*
Columbia, Missouri, 65201
United States
Recruiting Ali Khojasteh 573-893-6404
Royal Victoria Hospital, Barrie *Recruiting*
Barrie, Ontario, L4M 6M2
Canada
Recruiting Bryn Pressnail 705-728-9802
Queens Medical Associates, PC *Recruiting*
Fresh Meadows, New York, 11365
United States
Recruiting Barry Kaplan 718-460-2300 ext. 614
Leo W. Jenkins Cancer Center of University Health Systems of Eastern Carolina *Recruiting*
Greenville, North Carolina, 27858-4354
United States
Recruiting Jennie Crews 252-816-2560
Northern Virginia Oncology Group, P.C. *Recruiting*
Fairfax, Virginia, 22031
United States
Recruiting Catherine Broome 703-560-3205
Maine General Medical Center - Waterville *Recruiting*
Waterville, Maine, 04901
United States
Recruiting Andrew Hertler 207-872-1140
Northeastern Ontario Regional Cancer Centre - Sudbury *Recruiting*
Sudbury, Ontario, P3E 5J1
Canada
Recruiting Jonathan Noble 705-522-6237 - ext. 2512
CCOP - Dayton *Recruiting*
Dayton, Ohio, 45429
United States
Recruiting Howard Gross 937-395-8678
Nova Scotia Cancer Centre *Recruiting*
Halifax, Nova Scotia, B3H 1V7
Canada
Recruiting Daniel Rayson 902-473-6002
Oncology/Hematology Care, Incorporated *Recruiting*
Cincinnati, Ohio, 45236
United States
Recruiting David Waterhouse 513-793-6052
Advanced Oncology Associates *Recruiting*
Armonk, New York, 10504
United States
Recruiting Bernard Bernhardt 914-632-5397
Cancer Care Ontario - Windsor Regional Cancer Centre *Recruiting*
Windsor, Ontario, N8W 2X3
Canada
Recruiting Caroline Hamm 519-253-5253 ext. 58504
Staten Island University Hospital *Recruiting*
Staten Island, New York, 10305
United States
Recruiting Terenig Terjanian 718-226-6400
British Columbia Cancer Agency *Recruiting*
Vancouver, British Columbia, V5Z 4E6
Canada
Recruiting Karen Gelmon 604-877-6000
University of Colorado Cancer Center at University of Colorado Health Sciences Center *Recruiting*
Aurora, Colorado, 80010
United States
Recruiting Anthony Elias 720-848-1622
Durham Regional Cancer Centre at Lakeridge Health Oshawa *Recruiting*
Oshawa, Ontario, L1G 2B9
Canada
Recruiting Jose Chang 905-576-8711 ext. 4298
Hematology-Oncology Associates of Rockland, P.C. *Recruiting*
New City, New York, 10956
United States
Recruiting Robert March 845-362-1750
CCOP - Carle Cancer Center *Recruiting*
Urbana, Illinois, 61801
United States
Recruiting Kendrith Rowland 217-383-4083
Valley Hospital *Recruiting*
Ridgewood, New Jersey, 07450-2736
United States
Recruiting Thomas Rakowski 201-444-4526
CCOP - Iowa Oncology Research Association *Recruiting*
Des Moines, Iowa, 50309-1016
United States
Recruiting Roscoe Morton 515-244-7586
Northwestern Ontario Regional Cancer Care *Recruiting*
Thunder Bay, Ontario, P7B 6V4
Canada
Recruiting Dimitrios Vergidis 807-684-7200
Maisonneuve-Rosemont Hospital *Recruiting*
Montreal, Quebec, H1T 2M4
Canada
Recruiting Pierre Dube 514-252-3400 ext. 4672
Saint John Regional Hospital *Recruiting*
Saint John, New Brunswick, E2L 4L2
Canada
Recruiting Margot Burnell 506-648-6884
Redding Medical Center *Recruiting*
Redding, California, 96001-0853
United States
Recruiting Ajay Verma 530-244-5454
Associates in Oncology and Hematology *Recruiting*
Rockville, Maryland, 20850
United States
Recruiting John Wallmark 301-424-6231
Fraser Valley Cancer Centre at British Columbia Cancer Agency *Recruiting*
Surrey, British Columbia, V3V 1Z2
Canada
Recruiting Brian Norris 604-930-4064
Northern Indiana Oncology Associates - South Bend *Recruiting*
South Bend, Indiana, 46617
United States
Recruiting Rudolph Navari 574-472-6400
CCOP - Ochsner *Recruiting*
New Orleans, Louisiana, 70121
United States
Recruiting Carl Kardinal 504-842-3910
Mayo Clinic Cancer Center *Recruiting*
Rochester, Minnesota, 55905
United States
Recruiting Steven Alberts 507-284-4918
Moncton Hospital *Recruiting*
Moncton, New Brunswick, E1C 6ZB
Canada
Recruiting Sheldon Rubin 506-857-2881
Hotel Dieu Health Sciences Hospital - Niagara *Recruiting*
St. Catharines, Ontario, L2R 5K3
Canada
Recruiting Brian Findlay 905-682-6451
Somerset Medical Center *Recruiting*
Somerville, New Jersey, 08876
United States
Recruiting Kathleen Toomey 908-685-2481
Associates in Oncology and Hematology *Recruiting*
Chattanooga, Tennessee, 37404
United States
Recruiting Jitendra Gandhi 423-622-2337
CCOP - Merit Care Hospital *Recruiting*
Fargo, North Dakota, 58122
United States
Recruiting Preston Steen 701-234-6161
Trillium Health Centre *Recruiting*
Mississauga, Ontario, L5B 1B8
Canada
Recruiting John Gapski 905-270-3842
Arkansas Cancer Institute *Recruiting*
Pine Bluff, Arkansas, 71603
United States
Recruiting Omar Atiq 870-535-2800
Lone Star Oncology *Recruiting*
Austin, Texas, 78759
United States
Recruiting John Costanzi 512-343-2103
Centre Hospitalier de l'Universite de Montreal *Recruiting*
Montreal, Quebec, H2L 4M1
Canada
Recruiting Louise Yelle 514-890-8000, ext. 25381
Grand River Regional Cancer Centre *Recruiting*
Kitchner, Ontario, N2G 1G3
Canada
Recruiting Nadia Califaretti 519-749-4370
CCOP - Sioux Community Cancer Consortium *Recruiting*
Sioux Falls, South Dakota, 57104
United States
Recruiting Loren Tschetter 605-328-8044
Little Rock Hematology-Oncology Associates *Recruiting*
Little Rock, Arkansas, 72205
United States
Recruiting Brad Baltz 501-907-6444
Additional Information:
Study ID Numbers: CDR0000068520; NCCTG-CAN-NCIC-MA21,P-UPJOHN-CAN-NCIC-MA21,JANSSEN-CAN-NCIC-MA21,CAN-NCIC-MA21,AMGEN-CAN-NCIC-MA21,BMS-CAN-NCIC-MA21
Study Start Date:
Record last reviewed: July 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00014222
Other Stage 3a Breast Cancer Studies:
1. Tamoxifen to Prevent Bone Loss and Heart Disease in Premenopausal Women Receiving Chemotherapy for Stage I or Stage II Breast Cancer
2. Combination Chemotherapy Plus Biological Therapy in Treating Patients With Stage II or Stage III Breast Cancer
3. Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer
4. Cryosurgery in Treating Women With Breast Lesions
5. Vaccine Therapy With Either Neoadjuvant or Adjuvant Chemotherapy and Adjuvant Radiation Therapy in Treating Women With p53-Overexpressing Stage II or Stage III Breast Cancer
Related Studies:
Other stage 3A breast cancer Clinical Trials
Other British Columbia Clinical Trials
Other Vancouver Clinical Trials
Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer
|
|
|
|
|
|
|
|
